These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6609527)

  • 1. New perspectives in the diagnosis and treatment of adenosine deaminase (ADA) deficiency.
    Levinsky RJ; Davies EG; Simmonds HA; Webster DR; Adinolfi M
    Adv Exp Med Biol; 1984; 165 Pt A():33-8. PubMed ID: 6609527
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean.
    Giblett ER
    Ciba Found Symp; 1978; (68):3-18. PubMed ID: 115664
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
    Cowan MJ; Martin DW; Wara DW; Ammann AJ
    Adv Exp Med Biol; 1984; 165 Pt A():39-45. PubMed ID: 6609530
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy in adenosine deaminase and purine nucleoside phosphorylase deficient patients.
    Zegers BJ; Stoop JW
    Clin Biochem; 1983 Feb; 16(1):43-7. PubMed ID: 6407780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological failure caused by adenosine deaminase deficiency].
    Sylwestrowicz T; Gruchalska E
    Acta Haematol Pol; 1979; 10(3):205-10. PubMed ID: 116467
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlations between purine levels, clinical and immunological status in ADA deficiency.
    Simmonds HA; Fairbanks LD; Morris GS; Hugh-Jones K; Morgan G; Levinsky RJ
    Adv Exp Med Biol; 1986; 195 Pt A():93-9. PubMed ID: 3728190
    [No Abstract]   [Full Text] [Related]  

  • 7. Adenosine deaminase deficiency and severe combined immunodeficiency disease.
    Thompson LF; Seegmiller JE
    Adv Enzymol Relat Areas Mol Biol; 1980; 51():167-210. PubMed ID: 6255772
    [No Abstract]   [Full Text] [Related]  

  • 8. Purine metabolism and immunodeficiency: urinary purine excretion as a diagnostic screening test in adenosine deaminase and purine nucleoside phosphorylase deficiency.
    Simmonds HA; Sahota A; Potter CF; Cameron JS
    Clin Sci Mol Med; 1978 May; 54(5):579-84. PubMed ID: 108044
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete adenosine deaminase (ADA) deficiency without immunodeficiency, and primary hyperoxaluria, in a 12-year-old boy.
    Perignon JL; Hamet M; Cartier P; Griscelli C
    Adv Exp Med Biol; 1980; 122A():403-8. PubMed ID: 6968500
    [No Abstract]   [Full Text] [Related]  

  • 10. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune cell function and recycling of purines.
    Giblett ER
    N Engl J Med; 1976 Dec; 295(24):1375-6. PubMed ID: 824556
    [No Abstract]   [Full Text] [Related]  

  • 12. Red cell metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy.
    Staal GE; Stoop JW; Zegers BJ; van der Vlist MJ; de Bruyn CH; Wadman SK
    Monogr Hum Genet; 1978; 10():104-7. PubMed ID: 102921
    [No Abstract]   [Full Text] [Related]  

  • 13. Amelioration of neurologic abnormalities after "enzyme replacement" in adenosine deaminase deficiency.
    Hirschhorn R; Paageorgiou PS; Kesarwala HH; Taft LT
    N Engl J Med; 1980 Aug; 303(7):377-80. PubMed ID: 6156414
    [No Abstract]   [Full Text] [Related]  

  • 14. A role for purine metabolism in the immune response: Adenosine-deaminase activity and deoxyadenosine catabolism.
    Simmonds HA; Panayi GS; Corrigall V
    Lancet; 1978 Jan; 1(8055):60-3. PubMed ID: 74565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients.
    Markert ML; Hershfield MS; Schiff RI; Buckley RH
    J Clin Immunol; 1987 Sep; 7(5):389-99. PubMed ID: 3116034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D
    Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapid prenatal diagnosis of adenosine deaminase deficiency and other purine disorders using foetal blood.
    Simmonds HA; Fairbanks LD; Webster DR; Rodeck CH; Linch DC; Levinsky RJ
    Biosci Rep; 1983 Jan; 3(1):31-8. PubMed ID: 6839009
    [No Abstract]   [Full Text] [Related]  

  • 19. Progress in understanding the mechanism of immunodeficiency disease associated with defects in purine metabolism.
    Seegmiller JE
    Monogr Hum Genet; 1978; 10():88-91. PubMed ID: 102926
    [No Abstract]   [Full Text] [Related]  

  • 20. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.